Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-13-021279)

Filing Details

Accession Number:: 0001140361-13-021279
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-16 14:16:18
Reporting Period:: 2013-05-09

Filing Date:: 2013-05-16
Accepted Time:: 2013-05-16 14:16:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
730272	Repligen Corp	RGEN	Biological Products, (No Disgnostic Substances) (2836)	042729386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1263366	Jr F Thomas Ryan	C/O Repligen Corporation 41 Seyon Street, Bldg 1, Ste 100 Waltham MA 02453		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-09	5,342	$0.00	64,341	No	4	A	Direct
Common Stock	Disposition	2013-05-15	697	$8.99	63,644	No	4	S	Direct
Common Stock	Disposition	2013-05-15	264	$8.99	63,380	No	4	S	Direct
Common Stock	Disposition	2013-05-15	1,000	$9.00	62,380	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Mr. Ryan was awarded 5,342 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 9, 2014. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.